According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs.
Walgreens Boots Alliance Inc. (WBA, Financial) reached the 52-week high of $82.52
Walgreens Boots Alliance Inc. is a pharmacy led health and wellbeing company. It operates a retail pharmacy store chain in the U.S. The firm sells and markets its products under brands such as Walgreens, Duane Reade, Boots and Alliance Healthcare. Walgreens is one of the nation's largest retail pharmacies, with about 8,100 drugstores throughout the U.S. The firm recently acquired half of Rite Aid's locations, which will push its store count to approximately 10,000. This large network of stores enables the firm to reach a significant portion of the U.S. population, providing excellent brand recognition. Prescription drugs account for about two-thirds of sales, with the balance attributable to front-store products such as grocery, health and beauty items.
The price of Walgreens Boots Alliance Inc. shares has reached $82.52, which is 0.8% off the 52-week high of $83.18. Walgreens Boots Alliance Inc. has a market cap of $78.11 billion; its shares were traded around $82.52 with a price-earnings ratio of 16.31 and price-sales ratio of 0.62. The trailing 12-month dividend yield of Walgreens Boots Alliance Inc. stocks is 2.04%. The forward dividend yield of Walgreens Boots Alliance Inc. stocks is 2.13%. Walgreens Boots Alliance Inc. had an annual average earnings growth of 5.90% over the past 10 years. GuruFocus rated Walgreens Boots Alliance Inc. the business predictability rank of 3.5-star.
Walgreens Boots Alliance Inc. recently announced financial results for the fiscal year and fourth quarter that ended Aug. 31, 2018. Fiscal 2018 fourth-quarter net earnings attributable to Walgreens Boots Alliance increased 88.5% to $1.5 billion compared with the same quarter a year ago. Adjusted net earnings attributable to Walgreens Boots Alliance increased 4.5% to $1.4 billion, up 4.5% on a constant currency basis, compared with the same quarter a year ago. Adjusted earnings per share were $1.48, up 13% on both an actual and constant currency basis, compared with the same quarter a year ago. Sales in the fourth quarter were $33.4 billion, an increase of 10.9% from the year-ago quarter. Operating income was $1.5 billion, an increase of 35.6% from the same quarter a year ago. Net cash provided by operating activities was $2.9 billion in the fourth quarter, an increase of $866 million for the quarter.
Executive Vice President and Global Chief HRO Kathleen Wilson-Thompson sold 52,000 shares of Walgreens Boots Alliance stock on Oct. 31, 2018, at the price of $78.77 per share. The price of the stock has increased by 4.76% since.
NextEra Energy Inc. (NEE, Financial) reached the 52-week high of $180.39
NextEra Energy Inc. is an electric power company in North America. It generates renewable energy from wind and sun. The company also owns generation, transmission and distribution facilities and has investments in gas infrastructure assets. NextEra Energy's regulated utility, Florida Power & Light, distributes power to 4.5 million customers in Florida. Florida Power & Light contributes over 60% of the group's operating earnings. Consolidated generation capacity totals nearly 45 gigawatts and includes natural gas, nuclear and significant wind assets. The nonregulated segment generates and sells power throughout the U.S. and Canada.
The price of NextEra Energy Inc. shares has reached $180.39, which is 0.1% off the 52-week high of $180.60. Nextera Energy Inc. has a market cap of $86.22 billion; its shares were traded around $180.39 with a price-earnings ratio of 10.24 and price-sales ratio of 5.24. The trailing 12-month dividend yield of Nextera Energy Inc. stocks is 2.39%. The forward dividend yield of Nextera Energy Inc. stocks is 2.46%. Nextera Energy Inc. had an annual average earnings growth of 7.10% over the past 10 years.
NextEra Energy Inc. recently reported 2018 third-quarter net income attributable to NextEra Energy on a GAAP basis of $1.007 billion, or $2.10 per share, compared to $847 million, or $1.79 per share, for the third quarter of 2017. On an adjusted basis, NextEra Energy's 2018 third-quarter earnings were $1.039 billion, or $2.18 per share, compared to $875 million, or $1.85 per share, in the third quarter of 2017.
President and CEO of Sub Armando Pimentel Jr. sold 4,920 shares of NextEra Energy stock on Nov. 6, 2018, at the price of $170.11 per share. The price of the stock has increased by 6.04% since.
Verisk Analytics Inc. (VRSK, Financial) reached the 52-week high of $123.83
Verisk Analytics Inc. is a data analytics provider serving customers in insurance, natural resources and financial services. Verisk Analytics Inc. is a data analytics provider offering decision support and risk-management solutions to the financial industry. The company's predictive analytics are used in rating applications, underwriting, claims, catastrophe and weather risk assessment, global risk assessment, natural resources intelligence, economic forecasting and other related fields. Most of Verisk's revenue is based on long-term contracts and subscriptions. The largest end market is the risk assessment sector. Verisk's clients are located primarily in the U.S.
The price of Verisk Analytics Inc. shares has reached $123.83, which is 0.4% off the 52-week high of $124.32. Verisk Analytics Inc. has a market cap of $20.38 billion; its shares were traded around $123.83 with a price-earnings ratio of 31.75 and price-sales ratio of 8.88. Verisk Analytics Inc. had an annual average earnings growth of 14.40% over the past 10 years. GuruFocus rated Verisk Analytics Inc. the business predictability rank of 4.5-star.
Verisk recently announced results for the quarter ended Sept. 30, 2018. Highlights include:
-Revenue grew 9.0% to $599 million.
-Net income was $166 million; adjusted Ebitda, a non-GAAP measure, was $284 million.
-Net income grew 37.5%.
-Diluted GAAP earnings per share were 99 cents; diluted adjusted earnings per share, a non-GAAP measure, were $1.08.
-Net cash provided by operating activities was $761 million year-to-date. Free cash flow, a non-GAAP measure, was $607 million year-to-date.
Executive Vice President and Chief Operating Officer Mark V. Anquillare sold 53,125 shares of Verisk Analytics stock on Nov. 12, 2018, at the price of $122.86 per share. The price of the stock has increased by 0.79% since.
CMS Energy Corp. (CMS, Financial) reached the 52-week high of $51.02
CMS Energy Corp. is a utility company operating in Michigan. It is engaged in independent power production and owns power generation facilities fueled by natural gas and renewable sources. CMS Energy Corp. is an energy holding company with two principal segments: Consumers Energy and Enterprises. Consumers Energy provides regulated natural gas and electric service in Michigan to roughly 1.8 million customers in each business. Enterprises is engaged in wholesale power generation in various locations in the U.S. and owns EnerBank, primarily serving industrial customers.
The price of CMS Energy Corp. shares has reached $51.02, which is 1.7% off the 52-week high of $51.91. Cms Energy Corp. has a market cap of $14.46 billion; its shares were traded around $51.02 with a price-earnings ratio of 26.44 and price-sales ratio of 2.11. The trailing 12-month dividend yield of Cms Energy Corp. stocks is 2.80%. The forward dividend yield of CMS Energy Corp. stocks is 2.80%. CMS Energy Corp. had an annual average earnings growth of 7.90% over the past 10 years.
CMS Energy recently reported net income of $169 million, or 59 cents per share, for the third quarter of 2018. For the first nine months of the year, the company announced reported net income available to common stockholders of $549 million or $1.94 per share, and adjusted earnings per share of $1.93. The company raised its guidance for 2018 adjusted earnings per share to a range of $2.31 and $2.34 per share. Additionally, CMS Energy introduced 2019 adjusted earnings per share guidance of $2.46 to $2.50, reflecting continued growth of 6-8%.
Senior Vice President and Chief Information Officer Brian F. Rich sold 4,000 shares of CMS stock on Oct. 30, 2018, at the price of $49.69 per share. The price of the stock has increased by 2.68% since.
Johnson & Johnson (JNJ, Financial) reached the 52-week high of $147.38
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the healthcare field within its Consumer, Pharmaceutical and Medical Devices segments. Johnson & Johnson is the world's largest and most diverse health care company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. Close to half of total revenue is generated within the U.S.
The price of Johnson & Johnson shares has reached $147.38, which is 0.6% off the 52-week high of $148.32. Johnson & Johnson has a market cap of $395.27 billion; its shares were traded around $147.38 with a price-earnings ratio of 288.98 and price-sales ratio of 4.94. The trailing 12-month dividend yield of Johnson & Johnson stocks is 2.35%. The forward dividend yield of Johnson & Johnson stocks is 2.47%. Johnson & Johnson had an annual average earnings growth of 3.90% over the past 10 years. GuruFocus rated Johnson & Johnson the business predictability rank of 2-star.
Johnson & Johnson recently announced sales of $20.3 billion for the third quarter of 2018, an increase of 3.6% as compared to the third quarter of 2017. Operational sales results increased 5.5%, partially offset by the negative impact of currency of 1.9%. Net earnings and diluted earnings per share for the third quarter of 2018 were $3.9 billion and $1.44, respectively. Excluding after-tax intangible amortization expense and special items, adjusted net earnings for the current quarter were $5.6 billion and adjusted diluted earnings per share were $2.05, representing increases of 7.3% and 7.9%, respectively, as compared to the same period in 2017.
Chairman and CEO Alex Gorsky sold 264,465 shares of Johnson & Johnson stock on Nov. 16, 2018, at the price of $145.96 per share. The price of the stock has increased by 0.97% since.
Note: I do not own the stocks discussed.
